Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

NCT06827782 · clinicaltrials.gov ↗

PHASE1

Phase

ENROLLING_BY_INVITATION

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Refractory/Recurrent Central Nervous System Lymphoma

Interventions

BIOLOGICAL: anti-CD19 CAR-NK cells

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University